Table 2 Delay information for Window trials location in consent compared to patient preference
Key concepts | Purpose | Trial schedule | Beginning of risks section | End of risks section | |
|---|---|---|---|---|---|
Location of delay information in consent forms (n = 5) | 20% (1) | 40% (2) | 0 | 0 | 40% (2) |
Participant preferences for location of delay information (n = 17) | 18% (3) | 29% (5) | 6% (1) | 18% (3) | 24% (4) |